pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 11·1 min read
save

Nurses voice concerns on AI while regulators outline RAPID pathway for breakthrough devices

Aug 11, 2026·read at STAT ↗RegulatoryNeutral

The latest STAT Health Tech newsletter, dated August 11, 2026, highlights two contrasting developments in health technology.

Nurses interviewed for the piece express skepticism about the impact of artificial intelligence on clinical workflows, noting worries about accuracy, oversight and patient safety.

At the same time, the newsletter reports new guidance from the Centers for Medicare & Medicaid Services and the Food and Drug Administration on the RAPID (Rapid Access for Innovative Devices) pathway, which is intended to speed coverage decisions for breakthrough medical devices.

The combined coverage underscores the tension between rapid innovation and the need for careful clinical validation, a theme that will likely shape future policy and adoption.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: A RAPID proposal for breakthrough coverage, and nurses push back on AI”

read at STAT ↗
449 words · retrieved Aug 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoSTAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemicSTAT
  • 3h agoSTAT+: Lilly wins approval for once-weekly insulin shotSTAT
  • 4h agoOpinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drugSTAT
  • 5h agoSTAT+: Up and down the ladder: The latest comings and goingsSTAT
  • 5h agoSTAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and moreSTAT